| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |